Table 2 Number and proportion of seropositives adults (%)
Travelers (N = 124) | Diama (N = 38) | Ndiop (N = 40) | Dielmo (N = 45) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
pos | % | 95%CI | pos | % | 95%CI | pos | % | 95%CI | pos | % | 95%CI | |||||
LSA1-41 | 7 | 5,6% | 2,3% | 11,3% | 19 | 50% | 33% | 67% | 33 | 83% | 67% | 93% | 39 | 87% | 73% | 95% |
LSA1-J | 4 | 3,2% | 0,9% | 8,1% | 4 | 11% | 3% | 25% | 15 | 38% | 23% | 54% | 26 | 58% | 42% | 72% |
LSA3-NR2 | 1 | 0,8% | 0,0% | 4,4% | 3 | 8% | 2% | 21% | 7 | 18% | 7% | 33% | 15 | 33% | 20% | 49% |
LSA3-RE | 0 | 0,0% | 0,0% | 2,9% | 0 | 0% | 0% | 9% | 0 | 0% | 0% | 9% | 3 | 7% | 1% | 18% |
GLURP | 5 | 4,0% | 1,3% | 9,2% | 25 | 66% | 49% | 80% | 39 | 98% | 87% | 100% | 45 | 100% | 92% | 100% |
GLURP P3 | 1 | 0,8% | 0,0% | 4,4% | 7 | 18% | 8% | 34% | 21 | 53% | 36% | 68% | 15 | 33% | 20% | 49% |
SALSA1 | 0 | 0,0% | 0,0% | 2,9% | 7 | 18% | 8% | 34% | 23 | 58% | 41% | 73% | 24 | 53% | 38% | 68% |
SALSA2 | 2 | 1,6% | 0,2% | 5,7% | 16 | 42% | 26% | 59% | 23 | 58% | 41% | 73% | 43 | 96% | 85% | 99% |
TRAP1 | 0 | 0,0% | 0,0% | 2,9% | 0 | 0% | 0% | 9% | 3 | 8% | 2% | 20% | 2 | 4% | 1% | 15% |
TRAP2 | 0 | 0,0% | 0,0% | 2,9% | 0 | 0% | 0% | 9% | 0 | 0% | 0% | 9% | 1 | 2% | 0% | 12% |
STARP-R | 1 | 0,8% | 0,0% | 4,4% | 3 | 8% | 2% | 21% | 15 | 38% | 23% | 54% | 36 | 80% | 65% | 90% |
CSP | 7 | 5,6% | 2,3% | 11,3% | 10 | 26% | 13% | 43% | 32 | 80% | 64% | 91% | 43 | 96% | 85% | 99% |
SR11.1 | 1 | 0,8% | 0,0% | 4,4% | 9 | 24% | 11% | 40% | 12 | 30% | 17% | 47% | 29 | 64% | 49% | 78% |
SALIV1 | 0 | 0,0% | 0,0% | 2,9% | 3 | 8% | 2% | 21% | 2 | 5% | 1% | 17% | 5 | 11% | 4% | 24% |
SALIV2 | 1 | 0,8% | 0,0% | 4,4% | 0 | 0% | 0% | 9% | 0 | 0% | 0% | 9% | 0 | 0% | 0% | 8% |